Xtant Medical Holdings (XTNT) Accumulated Depreciation & Amortization (2016 - 2025)
Xtant Medical Holdings (XTNT) has disclosed Accumulated Depreciation & Amortization for 15 consecutive years, with $21.9 million as the latest value for Q3 2025.
- On a quarterly basis, Accumulated Depreciation & Amortization changed N/A to $21.9 million in Q3 2025 year-over-year; TTM through Sep 2025 was $21.9 million, a N/A change, with the full-year FY2024 number at $19.8 million, up 0.8% from a year prior.
- Accumulated Depreciation & Amortization was $21.9 million for Q3 2025 at Xtant Medical Holdings, up from $19.8 million in the prior quarter.
- In the past five years, Accumulated Depreciation & Amortization ranged from a high of $21.9 million in Q3 2025 to a low of $17.2 million in Q4 2021.
- A 5-year average of $18.6 million and a median of $18.0 million in 2022 define the central range for Accumulated Depreciation & Amortization.
- Peak YoY movement for Accumulated Depreciation & Amortization: increased 0.4% in 2021, then rose 9.55% in 2023.
- Xtant Medical Holdings' Accumulated Depreciation & Amortization stood at $17.2 million in 2021, then grew by 4.63% to $18.0 million in 2022, then grew by 9.55% to $19.7 million in 2023, then grew by 0.8% to $19.8 million in 2024, then increased by 10.2% to $21.9 million in 2025.
- Per Business Quant, the three most recent readings for XTNT's Accumulated Depreciation & Amortization are $21.9 million (Q3 2025), $19.8 million (Q4 2024), and $20.5 million (Q1 2024).